Pharmacelera Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
24
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$7.1M
- Investors
-
11
Pharmacelera General Information
Description
Developer of a drug discovery platform designed to explore large and diverse chemical spaces. The company's platform uses a 3D representation of molecules based on electrostatic, steric and hydrophobic interaction fields derived from semi-empirical quantum-mechanics calculations, enabling bioinformaticians and medicinal chemists to obtain results using benchmarked technology and boost their drug discovery projects.
Contact Information
Website
www.pharmacelera.comCorporate Office
- PCB, Torre R, 4a planta, Despatx A05, Parc Científic de Barcelona
- Carrer de Baldiri Reixac 4-8
- 08028 Barcelona
- Spain
Corporate Office
- PCB, Torre R, 4a planta, Despatx A05, Parc Científic de Barcelona
- Carrer de Baldiri Reixac 4-8
- 08028 Barcelona
- Spain
Pharmacelera Timeline
Pharmacelera Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 18-Feb-2026 | $7.1M | Completed | Generating Revenue | ||
| 7. Accelerator/Incubator | 01-Jul-2024 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 16-Jul-2023 | Completed | Generating Revenue | |||
| 5. Equity Crowdfunding | 05-May-2021 | Completed | Generating Revenue | |||
| 4. Grant | 02-Apr-2020 | Completed | Startup | |||
| 3. Grant | 08-Jan-2020 | Completed | Startup | |||
| 2. Grant | 23-Mar-2018 | $61.6K | Completed | Startup | ||
| 1. Accelerator/Incubator | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Pharmacelera Comparisons
Industry
Financing
Details
Pharmacelera Competitors (9)
One of Pharmacelera’s 9 competitors is Cyrus Biotechnology, a Venture Capital-Backed company based in Seattle, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cyrus Biotechnology | Venture Capital-Backed | Seattle, WA | ||||
| VLife Sciences Technologies | Formerly PE-Backed | Pune, India | ||||
| BPS Bioscience | Corporation | San Diego, CA | ||||
| Chemical Computing Group | Private Equity-Backed | Montreal, Canada | ||||
| OpenEye Scientific Software | Corporate Backed or Acquired | Santa Fe, NM |
Pharmacelera Patents
Pharmacelera Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4555519-A1 | Generating candidate molecule structure | Pending | 13-Jul-2022 | ||
| WO-2024013028-A1 | Generating candidate molecule structure | Inactive | 13-Jul-2022 | ||
| EP-3563274-A1 | Calculating molecular similarity | Pending | 29-Dec-2016 | ||
| WO-2018121866-A1 | Calculating molecular similarity | Inactive | 29-Dec-2016 | G16C20/30 |
Pharmacelera Signals
Pharmacelera Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Clave Capital | Hedge Fund | Minority | ||
| Inveready Asset Management | Venture Capital | Minority | ||
| Noso Capital | PE/Buyout | Minority | ||
| The Collider | Accelerator/Incubator | |||
| AVANÇSA | Government |
Pharmacelera FAQs
-
When was Pharmacelera founded?
Pharmacelera was founded in 2011.
-
Where is Pharmacelera headquartered?
Pharmacelera is headquartered in Barcelona, Spain.
-
What is the size of Pharmacelera?
Pharmacelera has 24 total employees.
-
What industry is Pharmacelera in?
Pharmacelera’s primary industry is Decision/Risk Analysis.
-
Is Pharmacelera a private or public company?
Pharmacelera is a Private company.
-
What is Pharmacelera’s current revenue?
The current revenue for Pharmacelera is .
-
How much funding has Pharmacelera raised over time?
Pharmacelera has raised $8.96M.
-
Who are Pharmacelera’s investors?
Clave Capital, Inveready Asset Management, Noso Capital, The Collider, and AVANÇSA are 5 of 11 investors who have invested in Pharmacelera.
-
Who are Pharmacelera’s competitors?
Cyrus Biotechnology, VLife Sciences Technologies, BPS Bioscience, Chemical Computing Group, and OpenEye Scientific Software are some of the 9 competitors of Pharmacelera.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process